Oncolytics Biotech Inc T.ONC

Be Right and sit tight.

[askretka]

Looks like there are several trials with results in Q4 expected that could move the stock. Still trying to wrap my head around the 15$ US target. It looks like it's a wait and see for now. HC Wainwright is one of the oldest and most successful banks in the US and Oncolyitcs has done presentations at their biotech conferences. ----------------- The following is pieces from Newman report from Canaccord analyst ----------- If ONCY can show increased activity detectable by a blood draw in combination with Tecentriq, Roche may choose to run a Phase 3 study in breast cancer, which we believe should substantially increase share value. ------------------------ Phase 2 BRACELET-1 study, which is part of its partnership Pfizer and Merck. If positive initial results are seen in this study, we believe it could potentially become the first part of a Phase 3 registrational study, Newman said. ------------------ If that wasnt enough, pelareorep could potentially be used in other indications. The company is hoping to publish interim data from its Phase 2 second-line study of the therapy in pancreatic cancer at ASCO in Q2 2020, with final data expected in Q4 2020. In addition, Newman noted, Data from the NCI-9603 multiple myeloma (MM) study is expected at ASCO in 2Q20 and the Opdivo combination MM study at ASH in 4Q2020. We note the opportunity to show efficacy across multiple tumor types using a tumor-agnostic biomarker would be a substantial benefit to ONCY and a significant catalyst to shares, in our view.

[MikeStock]

New to this stock. When you say expected Q4 do you mean those results are still pending an announcement? Thanks 

[MikeStock]

I guess the news this morning just answered my own question. Lol.